Clinical trial
A Multicenter, Prospective, Randomized, Controlled Clinical Trial of the Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus
NCT03061851 is registered in ClinicalTrials.gov with Qingdao Zhixin Health Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Randomized, Controlled Clinical Trial of the Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus
- Lead sponsor
- Qingdao Zhixin Health Technology Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 25, 2017
- Completion date
- December 31, 2018
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.